Powder: -20°C for 3 years | In solvent: -80°C for 1 year
Irsenontrine (E2027) maleate is a selective and orally active inhibitor of phosphodiesterase 9 (PDE9). It can be utilized in the study of neurological diseases.
Pack Size | Availability | Price/USD | Quantity |
---|---|---|---|
5 mg | Inquiry | $ 970.00 |
Description | Irsenontrine (E2027) maleate is a selective and orally active inhibitor of phosphodiesterase 9 (PDE9). It can be utilized in the study of neurological diseases. |
In vivo | Irsenontrine maleate, administered orally at doses of 0.3 and 3.3 mg/kg, significantly improves novel object exploration in scopolamine-induced rats at the higher dose [1]. Furthermore, a combined treatment of Irsenontrine maleate and memantine hydrochloride, each at 1 mg/kg orally, results in a significantly increased exploration of the novel object compared to treatment with memantine hydrochloride alone at the same dosage [1]. |
Synonyms | E2027 maleate |
Molecular Weight | 506.515 |
Formula | C26H26N4O7 |
CAS No. | 1630083-70-3 |
Powder: -20°C for 3 years | In solvent: -80°C for 1 year
You can also refer to dose conversion for different animals. More
bottom
Please see Inhibitor Handling Instructions for more frequently ask questions. Topics include: how to prepare stock solutions, how to store products, and cautions on cell-based assays & animal experiments, etc.
Irsenontrine maleate 1630083-70-3 E 2027 Maleate Irsenontrine Maleate E2027 Maleate E-2027 Maleate E2027 maleate inhibitor inhibit